A method for the determination of inorganic sulphate based on high performance ion chromatography is presented. The separation was performed on an anion-exchange column with a 1.8mmol/l sodium carbonate/ 1.7 mmol/1 sodium hydrogen carbonate-buffer, pH 10.35. Conductivity of the eluate was monitored after suppression of the background conductivity caused by the eluent-buffer.
Introduction
The main biological function of inorganic sulphate is to hydrolysis of the intermediate metabolite, pyrophosserve as a conjugation partner by forming sulphate esters phate, to orthophosphate. with hydroxyl groups of endogeneous or exogeneous The conjugation process depends on a sulphotransferase, metabolites. Adenosine triphosphate reacts with inor-which catalyses the transfer of a sulphate group to the ganic sulphate to form adenosine-S'-phosphosulphate alcoholic or phenolic hydroxyl groups of the metabolite and pyrophosphate; in a second reaction a phosphate from 3'-phosphoadenosine-5'-phosphate. Bile acids, stegroup is transferred from a second adenosine triphos-roids and catecholamines (1) are subject to this type of phate to adenosine-S'-phosphosulphate to give the conjugation, but sulphatation is also a vital step in the "active sulphate", 3'-phosphoadenosine-5'-phosphosul-biosynthesis of proteoglycans and metabolites like phate, as well as adenosine diphosphate. The reaction sulphocerebrosides. Sulphoconjugation also occurs in is thermodynamically partially driven by the enzymatic the detoxification of serveral drugs, for example salicyl-amide, α-methyldopa and acetaminophen, which contain alcoholic or phenolic hydroxyl groups.
In synovial fluid the concentration of inorganic anions is regulated by Donnan equilibrium, and the concentrations of anions like chloride and phosphate have been found to be higher than in serum. More recent studies (2) (3) (4) have shown that drugs used in the therapy of primary chronic polyarthritis decrease the sulphate content of the glycosaminoglycans synthesized in cartilage.
In the present study a high performance ion chromatography (HPIC) method for the determination of sulphate is reported. This was applied to the analysis of serum and synovial fluid. An ultrafiltration procedure suitable for the biological materials studied was used for the required deproteinization (5) (6) , and the effects of this sample preparation on the analytical results were minimized. A reference range for the concentration of sulphate in serum was established by analysing sera from 127 individuals. The concentrations of sulphate in synovial fluids from patients with chronic degenerative joint disease (n = 41) were compared with those in synovial fluids from patients with inflammatory joint disease (n = 36). Finally, the method was applied to kinetic studies on the metabolism of subtoxic dosis of acetaminophen in 4 healthy volunteers.
Materials and Methods

Chemicals
Potassium sulphate, 950 g/kg sulphuric acid, sodium carbonate, sodium hydrogen carbonate and 250 g/kg hydrochloric acid in at least p. a. quality were from Merck (Darmstadt, Germany). Isotonic sodium chloride solution (154 mmol/1) was from dilutee Salvia (Homburg/Saar, Germany). Hyaluronate lyase isolated from Streptomyces hyalurolyticus was obtained from Behringwerke AG (Liederbach, Taunus). The deionized water was prepared with a Milli-Q-apparatus (Millipore GmbH, Eschborn, Germany).
The acetaminophen used for the kinetic studies was orally administered to 4 healthy volunteers as ben-u-ron® 500 mg tablets in one dose (33-62.5 mg/kg weight).
For determination of acetaminophen in serum a fluorescence polarisation immunoassay was used. The appropriate reagent kits and controls for the TDX-FLX®-system were obtained from Abbott GmbH (Wiesbaden-Delkenheim, Germany).
All blood specimens were collected in Sarstedt serum monovettes containing separation gel. The reference range was determined from serum samples drawn after 12 h fasting, when the basic clinical chemistry (Na, K, C1, Ca, inorganic phosphate, total protein, total cholesterol, triacylglycerols, glucose, uric acid, urea, creatinine, total bilirubin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, alkaline phosphatase and total creatine kinase) did not show any pathological abnormalities.
The synovial fluids used in this study were obtained from diagnostic or therapeutic punctions of the knee joint of patients with inflammatory and chronic joint affections.
Instruments, settings and procedures
Ultrafiltration
The ultrafiltration was performed on an Amicon MPS-1 system with YMT 30 100PK 14 mm membranes (Amicon, Witten, Germany).
High performance ion chromatography
The Chromatographie analysis was performed on a HPLC-system consisting of an ion Chromatograph DX-100 (DIONEX GmbH, Idstein, Germany), containing an isocratic HPLC-pump and a conductivity detector, connected to an autosampler WISP 71 OB (Waters GmbH, Eschborn, Germany) and a Maxima 820 chromatography manager with a two channel system-interface-module (Waters GmbH, Eschborn, Germany) for system control, data acquisition and peak integration. The complete fluidic of the autosampler was passivated by 30% nitric acid before use.
For separation, an Ιοη-Pac AS4A (250 mm X 4 mm, DIONEX GmbH, Idstein, Germany), combined with a AG4A (40 mm X 4 mm, DIONEX GmbH, Idstein, Germany) was used. The eluent contained 1.7 mmol/1 Na 2 CO 3 and 1.8 mmol/1 NaHCO 3 in deionized water, pH 10.35; the flow rate was set to 2.0 ml/min; the pressure in the Chromatographie system did not exceed 140 bar. The retention times in this system were 1.2 min for fluoride, 2.3 min for chloride, 5.4 for phosphate and 6.2 min for sulphate.
The eluent of the column was passed through an anionic micromembrane suppressor AMMS-II (DIONEX GmgH, Idstein, Germany) integrated in the DIONEX DX-100 instrument for the elimination of the background conductivity caused by the carbonate buffer system. This ion exchanger was regenerated continuously by 50 mmol/1 sulphuric acid. The conductivity was measured at a sensitivity range of 10 μ8 full scale. The system was calibrated for sulphate concentrations between 10 μιηοΐ/ΐ and 100 μηιοΐ/ΐ sulphate with 4 standard solutions (10-25-50-100 μηιο1/1) prepared from a stock standard containing 1 mmol/1 sodium sulphate by volumetric dilution.
Analysis of the serum samples
Serum (150 μΐ) was diluted with deionized water to give a final volume of 1500 μΐ. Of this diluted serum 500 μΐ were filtered through the MPS-1-ultrafiltration device by centrifugation at 2000 g and 4 °C for 25 min; the resulting 400 μΐ ultrafiltrate were discarded. Then 900 μΐ diluted serum were filtered through the same membrane under the same conditions. Of this ultrafiltrate 50 μΐ were injected by the autosampler for analysis by ion chromatography.
Analysis of the synovial fluid samples
Hyaluronate lyase (150 mg, 300-400 Units/mg) was dissolved in 100 ml isotonic sodium chloride (154 mmol/1). Ten (10) μΐ of this solution were added to 300 μΐ synovial fluid and the mixture incubated for 30 min at 37 °C. After degradation of the hyaluronate the viscosity of the synovial fluid was comparable to that of serum. Hundred and fifty (150) μΐ of this mixture were then treated as described for serum samples.
Statistical calculations
All statistical calculations were done with the aid of the software package Jandel Sigmastat Version 1 (Jandel Scientific GmbH, Schimmelbuschstra e 25, D-40699 Erkrath, Germany). The Kolmogorov-Smirnov test with Lilliefors' correction was used to test data for normality of the estimated underlying population. The two sample t-test was used for the parametric comparison of two samples, which were drawn from normally distributed populations with the same variances.
Results
Chromatography
Ultrafiltration proved to be a suitable method of sample preparation for the determination of sulphate in serum and in synovial fluid. Figure la shows the chromatogram of a sulphate standard, figure Ib that of a serum ultrafiltrate, figure Ic that of a synovial fluid ultrafiltrate. Chloride and phosphate were well separated from sulphate, and no other anion interfering with sulphate was observed.
The signal of the conductivity detector was linear for injected amounts of 500 pmol to 50 nmol, equivalent to the concentration range 10 μηιο1/1-1000 μπιοΙ/1 (data shown in figure 2) .
Optimization of the ultrafiltration
The ultrafiltration membranes showed a significant content of sulphate and a capacity for the unspecific adsorption of sulphate. The recovery of an aqueous solution containing 0.625 umol/1 sulphate was 170-200%, that of a solution containing 80 μηιοΐ/ΐ sulphate was 80-90%, regardless of whether the membranes were previously conditioned with deionized water or not. This effect could be minimized by a two-step ultrafiltration procedure, discarding the ultrafiltrate of the first 500 μΐ aliquot of the diluted serum/synovial fluid, and using the second ultrafiltrate. Using this sample preparation we studied the effect of serum protein on the fraction of ultrafiltratable sulphate by standard recovery experi- ments. A serum pool (sulphate concentration: 350 umol/l) was prepared, then 150 μΐ serum pool, 150 μΐ of a sulphate standard and 1200 μΐ deionized water were mixed, and this dilution was ultrafiltered. Synovial fluids were pretreated with hyaluronate lyase, pooled and then processed like the pooled sera. Table 1 summarizes the results of these experiments, which showed a 100%-recovery for the range 5 μηιοΐ/ΐ to 40 μιηοΐ/ΐ sulphate added to both the 1 : 10 dilutions of the pooled sera and the 1 : 10 dilutions of the pooled synovial fluids.
Imprecision
The within-run imprecision (tab. 2a) was below 1.5% for standards, below 2.5% for the pooled sera and below 3.5% for the pooled synovial fluids. The between-run imprecision (tab. 2b) was about 3% for the pooled sera and below 6% for the pooled synovial fluids. The theoretical limit of detection was 1.05 μηιοΐ/l, determined by the method described by Long & Winefolder (7), considering the standard deviations of the quantities describing the calibration line, as well as the mean and 
Reference range in serum
The reference range for sulphate in serum was determined for serum samples from 69 male and 58 female subjects. The observed reference range showed no dependence on sex and age. For all 127 individuals the mean sulphate concentration in serum was 314 μηιοΙ/1 with a standard-deviation of 36 μηιοΙ/1, ranging from 262 μηιοΐ/l to 420 μηιοΙ/1. The data did not match the pattern expected for data drawn from a normal distributed population (Komolgorov-Smirnov-test, K-S distance = 0.1151, Ρ = 0.0007).
Sulphate concentration in pathological synovial fluids Figure 3 shows the distribution of the concentrations found for sulphate in pathological synovial fluids. For 36 synovial fluids from knees affected by inflammatory processes we obtained a range (mean ± standard deviation) of 424 μηιοΙ/1 ± 70.1 μηιοΐ/ΐ. For 41 synovial fluid from knees affected by chronic degenerative joint disease the range was (mean ± standard deviation) 374 μηιοΐ/l ± 69.9 μηιοΙ/1. The values for both groups were as expected for data drawn from a normally distributed population and showed an equal variance. Comparison of the two groups by a t-test revealed a difference for the mean values greater than would be expected by chance (t = 3.09 with 75 degrees of freedom, Ρ = 0.0028).
Kinetics of sulphate in serum following the administration of acetaminophen 5 60 1 2 3 4 5 60 1 2 3 4 5 60 1 2 3 4 5 6 Time after oral acetaminophen administration [h] The resorption and metabolism of acetaminophen could be described as a first order kinetic process with a resorption constant larger than the elimination constant. The peak concentration of acetaminophen reached in serum, calculated from the Bateman equation (8) used for fitting the data, was correlated with the applied dose normalized for body weight. The decay constant k 3 was 0.35 ± 0.06 h" 1 (mean ± standard deviation). The metabolism of acetaminophen showed a decay constant of 0.35 ± 0.06 h" 1 (mean ± standard deviation) for the four volunteers. In all cases, the decay kinetics of the sulphate in serum were also first order, but the variation of the decay constant k was large. Neither the kinetic constant nor the cumulative loss of sulphate in serum (41% to 74% of the initial sulphate concentration) due to the administration of acetaminophen were correlated with the applied dose of acetaminophen.
Discussion
The objective of this study was the determination of inorganic sulphate in serum and synovial fluid. Colorimetric methods using benzidine (9), barium chloranilate (10) or rhodizonate (11) as well as turbidimetric methods based on the detection of barium sulphate (12) have been described for the determination of inorganic sulphate in biological materials. All these methods have limited sensitivity and precision due to the required sample preparation procedures and the analytical principle; the results are also strongly influenced by the matrix of the sample analysed. Several slightly different methods for the determination of sulphate in serum by high-performance-ion-chromatography with conductivity detection have also been described (5, 13 -16) . The advantage of these methods is that deproteinization is the only sample pretreatment required. Furthermore, the quantification does not depend on the use of an internal standard. In the present study ultrafiltration was choosen for deproteinization, since it is more effective than precipiTab. 3 Kinetic studies on sulphate consumption due to acetaminophen administration. The kinetic of sulphate consumption was approximated as c(t) = c x + (c 0 -c«) · e" The kinetic of acetaminophen was approximated as c(t) tation (16) . No interference by a precipitation agent can occur, and sample preparation is much more reproducible and allows better standardization. The only drawback is the unspecific binding of sulphate to the ultrafiltration membranes. Methods for elimination of sulphate contamination of the ultrafiltration membranes have been described previously (5-6), but the issue of unspecific binding of the analyte from the samples to the membranes, leading to a reduced recovery as well as precision, was not addressed. The method described here involves a sequence of two ultrafiltrations of diluted aliquots of a sample. The function of the first step was to equilibrate the membranes with the sulphate of the individual samples; the ultrafiltrate obtained was discarded. Analysis of the ultrafiltrate of the second aliquot showed an imprecision lower than 2%. The inaccuracy, assessed by standard recovery experiments, was also within these limits.
The reference range for sulphate in serum was studied in samples from blood-donors and apparently healthy volunteers and did not show any dependence on age and sex. The mean concentration in serum was 314 μηιοΐ/l, and a broad, non-normal distribution from 242 μπιοΐ/ΐ to 385 μηιοΐ/ΐ was observed. This non-normal distribution may be due to inter-individual as well as intra-individual fluctuations of the sulphate concentration in serum arising from the present pool and recent intake of sulphate-generating aminoacids as well as the renal sulphate elimination. Since all samples were drawn in the morning from individuals who had fasted for at least 12 hours, effects due to recent nutritive ingestion of sulphate precursors and due to a circadian rhythm described previously (17) should have been prevented.
Furthermore we studied the sulphate concentration in 36 synovial fluids from knees affected by inflammatory processes and 41 synovial fluids from knees affected by chronic degenerative joint disease.
Non-pathological synovial fluids from patients without any joint disease were not available for ethical reasons, so the study was limited to the comparison of the two major groups defined by the criteria described previously (18) (19) . For the group of synovial fluids from patients suffering from inflammatory joint disease the sulphate concentrations found were significantly higher (t-test) than those found for the group of synovial fluids from patients suffering from chronic degenerative joint disease. There may be several reasons for the differences between the two groups. Due to the greater permeability of the blood-synovia-barrier in the case of inflammatory joint diseases, the higher sulphate concentration cannot be described as analogous to the higher protein concentrations found in these cases, because the concentrations of most constituents in synovial fluid approach the concentrations in serum with increasing permeability of the blood-synovia-barrier (19) . An association of the differences in the concentrations of sulphate in the synovial fluid with the inflammatory activity of the joint process seems more likely. In inflammatory joint disease the metabolic activity in the synovial system and the degradation of the joint cartilage with degradation of sulphated proteoglycans and glycosaminoglycans are accelerated. Besides these processes there is an induction of biosynthetic activity for the reconstruction of the components of the synovial system mediated by cytokines and growth factors (20) . Activation of regulatory processes enhancing the synthesis of new sulphated proteoglycans may therefore also be responsible for the higher concentration of sulphate in the synovial fluid in cases of inflammatory joint disease.
In four volunteers we studied the changes of concentration of sulphate in serum due to an intake of acetaminophen. An exponential time-dependent decrease of the concentration of sulphate in serum accompanying the elimination of acetaminophen was observed. The decay constant as well as the cumulative concentration decrease of sulphate in serum were not correlated with the dose of acetaminophen normalized for body weight, or with the peak acetaminophen concentration in serum.
The role of sulphate in cellular metabolism as well as the sulphate depletion in serum due to drug metabolism have been described by other authors (21 -24) . This sulphate trapping may be an intrinsic effect of antiinflammatory drugs (22) (23) . Chronic intake of drugs subject to conjugation with sulphate may lead to a permanently reduced sulphate concentration in serum. Sulphate trapping by drugs in serum may consecutively lead to a reduced sulphate concentration in the synovial fluid. Sulphate is necessary for the biosynthesis of sulphated proteoglycans, so that sulphate depletion in the synovial fluid may have a negative impact on the quantity and the composition of the proteoglycans synthesized (2-4). These altered proteoglycans may enhance the destruction of the cartilage. Since several drugs used commonly in pain therapy of arthritis have sulphate-depleting effects like acetaminophen (24) , this sulphate trapping may manifest itself as an adverse side-effect. The potential of such drugs for enhancing the progression of the cartilage destruction has to be studied further in clinical trials.
The determination of sulphate in serum may also be useful for the follow-up of patients suffering from intoxication with acetaminophen. Since the pool of sulphate is limited and may only be restored by metabolism of sulphur-containing amino acids, the course of the concentration of sulphate in serum gives additional important information in these circumstances. In animal experiments, a permanently low sulphate concentration in serum has been shown to result in non-linear kinetics and decreased efficiency for the elimination of drugs (25) .
